Test Price
850 AED✅ Home Collection Available
Measles (Rubeola) Antibodies Panel IgG & IgM Test – DHA-Licensed | 850 AED | Dubai
Executive Summary & Core Metrics
- ✓Accuracy Guarantee: 99.9% Diagnostic Sensitivity via CLIA (Chemiluminescent Immunoassay) processed in ISO 9001:2015 accredited laboratories (Cert: INT/EGQ/2509DA/3139).
- ✓Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain transport; VIP Mobile Phlebotomy available across all emirates.
- ✓Clinical Guidance: Complimentary Telephonic Post-Test Clinical Guidance for result interpretation by DHA-licensed physicians.
- ✓Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
The Measles (Rubeola) Antibodies Panel IgG & IgM delivers a comprehensive serological immunity assessment with 99.9% diagnostic sensitivity. This CLIA-based panel differentiates prior immunity from acute infection and supports vaccination verification, outbreak surveillance, and febrile illness differential diagnosis. Price: 850 AED. DHA Facility License: 1143.
Test Overview & Methodology
The Measles (Rubeola) Antibodies Panel IgG & IgM is a dual-marker serological assessment designed to differentiate between prior immunity (IgG) and acute or recent measles infection (IgM). This CLIA-based panel is indispensable for vaccination status verification, outbreak surveillance, and differential diagnosis of febrile exanthematous illness. The IgG component identifies long-term humoral protection from prior MMR vaccination or natural infection, while IgM serves as the acute-phase marker detectable within 3–7 days of rash onset and persisting up to 8 weeks.
| Feature | Our CLIA Panel (ISO Certified) | Standard ELISA Alternative |
|---|---|---|
| Methodology | CLIA (Chemiluminescent Immunoassay) | ELISA (Enzyme-Linked Immunosorbent Assay) |
| Diagnostic Sensitivity | 99.9% | 85–92% |
| Turnaround Time | Same Day (Sample by Fri 9 AM) | 2–5 Business Days |
| Quantitative Range | Wide Dynamic Range (Automated) | Narrower; manual interpretation |
| ISO 9001:2015 Accreditation | ✓ Certified (INT/EGQ/2509DA/3139) | Variable / Not Guaranteed |
| Home Collection | ✓ Cold-Chain VIP Phlebotomy | Limited Availability |
Physician Insight & Safety Protocols
"Serological profiling for measles antibodies plays a critical role in population-wide immunity surveillance across the UAE. A reactive IgM result demands immediate clinical correlation with symptom chronology and immunization records, as cross-reactivity with parvovirus B19, EBV, or rheumatoid factor can produce false-positive readings. Isolated serology without clinical context should never guide diagnostic decisions. Always consult your physician to integrate these laboratory findings with your complete medical history and physical examination."
— Dr. Ajay Singh, DHA License No: 36234132, General Practitioner
Important Medication Advisory
Medication Awareness Prior to Testing
Never alter or discontinue prescribed treatments without explicit guidance from your physician. Immunomodulatory agents, including systemic corticosteroids, biologic therapies, and disease-modifying antirheumatic drugs (DMARDs), can alter antibody synthesis and potentially skew serological readouts. Provide a complete medication inventory to both your phlebotomist and referring clinician before sample collection.
Patient Exclusion Criteria & Emergency Red Flags
Home Collection Exclusion Criteria:
- Active febrile illness with temperature ≥ 38.5°C
- Severe thrombocytopenia or bleeding diathesis
- Known history of vasovagal syncope during venipuncture
- Patients under 12 years require guardian presence for home collection; pediatric collection protocols apply
- Uncontrolled seizure disorder
Emergency Red Flags — Seek Immediate Medical Attention:
- High fever with photophobia and Koplik spots (pathognomonic for measles)
- Acute encephalopathy or seizures post-exanthem
- Severe respiratory distress with diffuse rash
- Signs of subacute sclerosing panencephalitis (SSPE) — behavioral changes, myoclonus
- Anaphylaxis following any prior vaccination
Patient FAQ & Clinical Guidance
1. What is the Measles (Rubeola) Antibodies Panel IgG & IgM used for?
This serological panel simultaneously detects IgG and IgM antibodies to determine past immunity, vaccination response, or active measles infection with 99.9% diagnostic sensitivity. The IgG component identifies long-term immunity — either from prior vaccination (MMR) or natural infection — while IgM serves as the acute-phase marker, typically detectable within 3–7 days of rash onset and persisting up to 8 weeks. This dual-marker approach is the DHA-recommended strategy for outbreak investigation, pre-travel health clearance, and assessment of immunocompromised patients who cannot receive live-attenuated vaccines. Clinical correlation with patient history is mandatory for accurate interpretation.
2. How should I prepare for the Measles Antibodies Panel test?
No fasting or special preparation is required for this test; blood collection can be performed at any time during the day. A 2 mL venous blood sample is drawn into a serum separator tube (SST) by our DHA-licensed mobile nursing team. Do not discontinue any prescribed medication unless explicitly directed by your physician. Inform the nursing team about any immunosuppressive therapies or supplements you are currently taking. The sample is transported under ISO-certified cold-chain conditions to preserve specimen integrity. Results are reported the same day when the sample is received before 9 AM on Friday.
3. What do positive IgG and negative IgM results indicate about my immunity?
A positive IgG with negative IgM confirms established immunity to measles — either from successful MMR vaccination or past natural infection — indicating robust long-term protection. This serological profile is the most common finding in adequately vaccinated adults and signifies no current or recent infection. Conversely, positive IgM (with or without positive IgG) requires urgent clinical evaluation, as it suggests acute measles infection or recent vaccination within the preceding 6–8 weeks. Isolated positive IgM without IgG warrants repeat testing in 7–10 days to confirm seroconversion. False-positive IgM may occur with cross-reacting viruses (EBV, parvovirus B19) or in the presence of rheumatoid factor; therefore, all results must be correlated with clinical symptoms by your DHA-licensed physician before any diagnostic conclusion is drawn.
UAE Regulatory & Data Privacy Adherence
Federal Decree-Law No. 45 of 2021 (PDPL)
All patient data, serological results, and personal health information are processed and stored in full compliance with the UAE Personal Data Protection Law. Encryption and access controls meet or exceed regulatory standards for health information confidentiality.
Federal Law No. 2 of 2019 (ICT Health)
All diagnostic laboratory systems and health information technology infrastructure comply with Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, ensuring secure data exchange and interoperability.
Federal Decree-Law No. 4 of 2016 (Medical Liability)
Clinical testing safety, patient consent protocols, and phlebotomy procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability, guaranteeing informed consent and professional accountability throughout the diagnostic pathway.
Clinical & Logistical Metadata
| Test Name | Measles (Rubeola) Antibodies Panel IgG & IgM |
| Price (AED) | 850 AED |
| Turnaround Time | Same Day (Sample by Fri 9 AM) |
| Sample Type / Matrix | Serum (2 mL from 1 SST) |
| Methodology Used | CLIA (Chemiluminescent Immunoassay) |
| ICD-10-CM Code | B05.9, Z20.1, Z11.59 |
| LOINC Code | 35275-7, 35276-5 |
| DHA Facility License & Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians